.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Citi
Mallinckrodt
Healthtrust
UBS
US Army
Julphar
Moodys
Baxter
Boehringer Ingelheim

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203690

« Back to Dashboard

NDA 203690 describes NICOTINE POLACRILEX, which is a drug marketed by Actavis Labs Ny Inc, Ivax Sub Teva Pharms, L Perrigo Co, Perrigo R And D, and Watson Labs, and is included in thirty-four NDAs. It is available from thirty-nine suppliers. Additional details are available on the NICOTINE POLACRILEX profile page.

The generic ingredient in NICOTINE POLACRILEX is nicotine polacrilex. There are twenty-nine drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.

Summary for 203690

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 203690

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 203690 ANDA L. Perrigo Company 0113-0734 0113-0734-03 4 CONTAINER in 1 CARTON (0113-0734-03) > 27 LOZENGE in 1 CONTAINER
NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 203690 ANDA L. Perrigo Company 0113-0734 0113-0734-02 3 CONTAINER in 1 CARTON (0113-0734-02) > 27 LOZENGE in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TROCHE/LOZENGE;ORALStrengthEQ 2MG BASE
Approval Date:Oct 9, 2012TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TROCHE/LOZENGE;ORALStrengthEQ 4MG BASE
Approval Date:Oct 9, 2012TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cipla
Covington
Citi
Medtronic
US Army
Deloitte
Argus Health
McKinsey
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot